Diethyldithiocarbamate, a novel immunomodulator, prolongs survival in autoimmune mice
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 55 (2) , 242-254
- https://doi.org/10.1016/0090-1229(90)90100-5
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice.The Journal of Experimental Medicine, 1988
- A shared B-T cell phenotype in autoimmune mice bearing the lpr geneClinical Immunology and Immunopathology, 1987
- Antihistone antibodies detected by micro-ELISA and immunoblotting in mice with lupus-like syndrome (MRL/l, MRL/n, PN, and NZB strains)Clinical Immunology and Immunopathology, 1986
- Decreased In Vivo Functional T Cell Capacity in the Murine Autoimmune Strains MRL/Mp-lpr/lpr and Male BXSB/MpImmunobiology, 1986
- The Effects of Diethyldithiocarbamate on the Hepatotoxic Action and Antitumor Activity of N-Methylformamide in MiceThe Japanese Journal of Pharmacology, 1985
- The generation and regulation of human T lymphocytes by imuthiol. Evidence from an in vitro differentiation induction systemInternational Journal of Immunopharmacology, 1985
- Quantitative studies on T-cell functions in miceClinical Immunology and Immunopathology, 1984
- Flow cytometry analysis of T cells and continuous T-cell lines from autoimmune MRL/l miceNature, 1981
- Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.The Journal of Experimental Medicine, 1978
- Metabolic balance studies in hepatolenticular degeneration treated with diethyldithiocarbamateThe American Journal of Medicine, 1963